Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 397

1.

Commentary: Epidemiology and the pharmaceutical industry: an inside perspective.

Haas J.

Int J Epidemiol. 2008 Feb;37(1):53-5; discussion 65-8. doi: 10.1093/ije/dym264. No abstract available.

2.

Commentary: Lack of scientific influences on epidemiology.

Phillips CV.

Int J Epidemiol. 2008 Feb;37(1):59-64; discussion 65-8. doi: 10.1093/ije/dym266. No abstract available.

3.

Does pharmaceutical marketing actually have real and proven value?

Muller D, Adler L.

J Gen Intern Med. 1997 Apr;12(4):258. No abstract available.

4.

Corporate influences on epidemiology.

Pearce N.

Int J Epidemiol. 2008 Feb;37(1):46-53. doi: 10.1093/ije/dym270. Review.

5.
6.

Corporate moral culpability in health care: when the implications don't fit the crime.

Harter TD.

Am J Bioeth. 2011 Sep;11(9):12-3. doi: 10.1080/15265161.2011.593684. No abstract available.

PMID:
21877964
7.

Commentary: Addressing corporate influence through ethical guidelines.

Greenland S.

Int J Epidemiol. 2008 Feb;37(1):57-9; discussion 65-8. doi: 10.1093/ije/dym267. No abstract available.

8.

Conflict of interest in the physician interface with the biomedical industry.

Minnigan H, Chisholm CD.

Emerg Med Clin North Am. 2006 Aug;24(3):671-85. Review.

PMID:
16877136
9.

Pharmaceutical GMPs.

Bobrowicz G.

Qual Assur. 1994 Jun;3(2):138-48. No abstract available.

PMID:
7804629
10.

Vioxx, radiology, and the Food and Drug Administration.

Pentecost MJ.

J Am Coll Radiol. 2005 May;2(5):394-7. No abstract available.

PMID:
17411841
11.
12.

Clinical research: outlook from industry.

Echols R.

Clin Perform Qual Health Care. 1996 Apr-Jun;4(2):113-4. No abstract available.

PMID:
10156942
13.

The economic wisdom of regulating pharmaceutical "freebies".

Fisher SH.

Duke Law J. 1991 Feb;(1):206-39. No abstract available.

PMID:
10114416
14.

The role of the pharmaceutical industry in drug development and approval.

Beleau MH.

Vet Hum Toxicol. 1998;40 Suppl 2:17-9. No abstract available.

PMID:
9823577
15.

Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry.

Keim S, Perina DG; CORD Board of Directors..

Acad Emerg Med. 2004 Jan;11(1):78. No abstract available.

16.

Clinical investigators and the pharmaceutical industry.

Bellin E.

N Engl J Med. 2000 Aug 17;343(7):511. No abstract available.

17.

Physicians and the pharmaceutical industry: a dysfunctional relationship.

Fisher MA.

Perspect Biol Med. 2003 Spring;46(2):254-72.

PMID:
12721524
18.

Fear of bias puts spotlight on drug approval.

Wadman M.

Nature. 2001 Jun 28;411(6841):981. No abstract available.

PMID:
11429559
19.
20.

The pharmaceutical industry: friend or foe?

Niebyl JR.

Am J Obstet Gynecol. 2008 Apr;198(4):435-9. doi: 10.1016/j.ajog.2007.11.055. No abstract available.

PMID:
18395035
Items per page

Supplemental Content

Support Center